查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
幹細胞市場：規模、份額、趨勢分析報告：副產品（成人幹細胞、人類胚胎幹細胞）、應用、技術、治療、最終用途、地區、細分市場預測，2022-2030 年
市場調查報告書
商品編碼
1147480

幹細胞市場：規模、份額、趨勢分析報告：副產品（成人幹細胞、人類胚胎幹細胞）、應用、技術、治療、最終用途、地區、細分市場預測，2022-2030 年

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application, By Technology, By Therapy, By End Use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

幹細胞市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球幹細胞市場規模預計將達到 316 億美元，2022 年至 2030 年的複合年增長率為 11.4%。幹細胞是可以分化成各種其他細胞並最終形成器官和組織的細胞。多年來進行了許多研究來評估幹細胞的真正潛力，從而在遺傳疾病治療、神經系統疾病、腫瘤和器官再生等領域產生了各種應用。銀行數量的增加、對增強這些產品的治療潛力的日益關注以及對再生醫學發展的廣泛研究推動了市場的發展。

對再生醫學日益增長的興趣正在推動市場擴張。 iPS 細胞越來越受歡迎，因為它們被用於創建定制的細胞療法並為再生醫學開闢了新的可能性。例如，2020 年 9 月，杜克國立大學和莫納什大學的研究人員發現了第一個可以幫助治療妊娠期胎盤問題的干細胞。研究人員設計了一種生產人造絨毛幹細胞的新方法，該干細胞可用於產生胎盤細胞。這項研究將有助於開發體外人胎盤模型，並為未來的治療鋪平道路。

此外，COVID-19 正在充當促進市場增長的催化劑。包括美國、中國和伊朗在內的幾個國家已經開始進行使用細胞療法治療 COVID-19 感染的臨床試驗。此外，使用細胞療法治療 COVID-19 患者取得了優異的效果，這正在推動市場擴張。 2020 年 1 月，中國北京的一個研究小組進行了一項患者試驗，以了解幹細胞療法是否對 COVID-19 有益。該研究發現，在第一次治療試驗期間，向 COVID-19 患者靜脈注射臨床級 MSCs 可改善功能結果並加速康復。

癌症患病率的增加是導致預測期內增長的關鍵因素之一。聯合療法和化學療法在癌症治療中的失敗導致醫生從這些方式轉向自體和同種異體幹細胞療法，從而促進生長。此外，主要市場參與者和政府機構繼續投資於癌症研究。例如，2021年11月，加州再生醫學研究所將投資400萬美元用於治療急性淋巴細胞白血病（ALL）、慢性淋巴細胞白血病（CLL）和套細胞淋巴瘤（MCL）患者。

用於使用和採用基於細胞的療法的新技術的引入預計將在預測期內推動增長。成人幹細胞和臍帶血處理和儲存的自動化是一項關鍵技術，有望對市場增長產生積極影響。例如，許多科學家正在尋求批准使用乾細胞治療多種疾病的安全且成功的方法。 2021 年，Biotech Cellino 等公司將投資 7500 萬美元，努力融合人工智能技術以開發自動化干細胞製造，旨在以經濟高效的方式標準化細胞療法的獲取。

另一方面，高昂的治療費用預計會阻礙市場增長。例如，幹細胞研究公司 Bioinformant 報告稱，每位患者的干細胞治療費用在 5,000 美元到 8,000 美元之間，在某些情況下超過 25,000 美元，具體取決於手術的複雜程度。此外，對乾細胞研究活動的限制傳統上阻礙了胚胎幹細胞的生長，導致儘管它們具有優勢，但整體市場份額很小。

幹細胞市場報告亮點

被認為是乾細胞治療黃金標準的 ASCs 領域在 2021 年佔據了最大份額。一致的臨床成功，特別是在造血幹細胞移植方面，已導致廣泛接受並且關於其來源的爭議相對較少。

從 2022 年到 2030 年，iPSC 預計將以復合年增長率增長。這是因為越來越多的公司正在使用 iPS 進行細胞治療。例如，2020 年 7 月，Cynata Therapeutics Limited 宣布了其旗艦產品 iPS 細胞衍生的 Cymerus CYP-001的一期臨床試驗的積極結果。

由於政府增加了對再生醫學發展的資助，再生醫學在 2021 年佔據了市場主導地位。例如，2020 年 10 月，AusBiotech 牽頭的財團從 MTPConnect 的 Industry Growth Center Project Fund 獲得了 30 萬美元的資助，用於澳大利亞的再生醫學發展

細胞收穫技術將在 2021 年佔據最大的市場份額，並且由於涉及細胞收穫的研究調查不斷增加，預計從 2022 年到 2030 年將以最快的複合年增長率增長

由於異基因幹細胞移植在癌症治療中的增加，2021年異基因療法將主導市場

製藥和生物技術公司將在 2021 年佔據最大的市場份額，並且由於研發活動的增加、臨床試驗的增加以及主要參與者的戰略行動，預計將以最快的複合年增長率增長。

北美市場包括美國和加拿大。該地區的市場增長是由強大的政府資金、不斷增加的研究以及該地區領先企業的存在推動的。

由於主要參與者的業務擴張，預計從 2022 年到 2030 年，亞太地區將以最快的複合年增長率增長。例如，2020 年 4 月，Seneca Biopharma 在中國蘇州完成了一個新的干細胞製造工廠。

內容

第 1 章：研究技術

  • 市場細分和範圍
  • 調查技術
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法逐個國家/地區進行市場估算
  • 全球市場：CAGR 計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的
  • 縮寫列表

第二章市場定義

第 3 章執行摘要

  • 市場概覽

第 4 章全球幹細胞市場市場：變量、趨勢和範圍

  • 幹細胞市場譜系展望
    • 母公司市場展望
  • 描繪滲透率和增長前景
  • 監管框架
  • 市場驅動因素分析
    • 再生醫學的發展
    • 增加資金以加速乾細胞研究
    • 對乾細胞銀行業務的需求不斷增長
    • 遺傳病患病率增加
  • 市場製約因素分析
    • 關於乾細胞研究的倫理問題
    • 缺乏針對乾細胞特定用途的明確監管框架
  • 主要機會
    • 對細胞和基因療法的需求
  • 主要問題
    • 與製造過程相關的技術限制
  • 幹細胞市場 - PESTLE 分析
  • 行業分析 - 搬運工
  • 對主要交易和戰略聯盟的分析
    • 合資企業
    • 併購
    • 許可和合作夥伴關係
    • 技術合作
    • 戰略銷售
  • COVID-19 影響分析

第 5 章幹細胞市場：細分分析，按產品分類，2018-2030 年（百萬美元）

  • 全球幹細胞市場：產品波動分析
  • 成體幹細胞 (ASC)
    • 造血幹細胞（血液幹細胞）
    • 間充質乾細胞
    • 神經乾細胞
    • 上皮/皮膚幹細胞
    • 其他成體幹細胞
  • 人類胚胎幹細胞
  • 誘導多能幹細胞
  • 非常小的類胚胎幹細胞

第 6 章幹細胞市場：細分分析，按應用，2018-2030（百萬美元）

  • 幹細胞市場：應用的變化分析
  • 再生醫學
    • 神經學
    • 骨科
    • 腫瘤科
    • 血液學
    • 心血管和心肌梗塞
    • 受傷
    • 糖尿病
    • 肝損傷
    • 尿失禁
    • 其他
  • 藥物發現和開發

第 7 章幹細胞市場：細分分析，按技術，2018-2030 年（百萬美元）

  • 全球幹細胞市場：技術波動分析
  • 獲取單元格
    • 骨髓採集
    • 臍帶血
    • 單採術
  • 細胞生產
    • 治療性克隆
    • 體外受精
    • 細胞培養
    • 隔離
  • 冷凍保存
  • 擴張和亞文化

第 8 章幹細胞市場：按療法細分分析，2018-2030（百萬美元）

  • 全球幹細胞市場：治療波動分析
  • 首頁
  • 同種異體

第 9 章幹細胞市場：細分分析，按最終用戶，2018-2030 年（百萬美元）

  • 全球幹細胞市場：最終用戶波動分析
  • 製藥和生物技術公司
  • 醫院和細胞庫
  • 學術和研究機構

第 10 章幹細胞市場：按地區劃分的細分分析，2018-2030 年（百萬美元）

  • 幹細胞市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第11章競爭格局

  • 上市公司
    • 公司市場分析
    • 競爭儀表板分析
    • 戰略框架
  • 私人公司
    • 主要初創企業/技術顛覆者/創新者名單
    • 本地網絡網絡地圖
  • 公司簡介
    • ADVANCED CELL TECHNOLOGY, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • STEMCELL Technologies, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELLULAR ENGINEERING TECHNOLOGIES INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELLGENIX GmbH
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PROMOCELL GMBH
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • LONZA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • KITE PHARMA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELLARTIS AB
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ANGEL BIOTECHNOLOGY
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • BRAINSTORM CELL THERAPEUTICS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELGENE CORPORATION
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • OSIRIS THERAPEUTICS, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • GENEA BIOCELLS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • BIOHEART INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • WAISMAN BIOMANUFACTURING
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • TIGENIX
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CALADRIUS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • GAMIDA CELL.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PLURISTEM THERAPEUTICS INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: 978-1-68038-130-6

Stem Cells Market Growth & Trends:

The global stem cells market size is expected to reach USD 31.6 billion by 2030, registering a CAGR of 11.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery.

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective.

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages.

Stem Cells Market Report Highlights:

  • ASCs segment accounted for the largest share in 2021 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
  • The iPSC segment is expected to witness a lucrative CAGR through 2022-2030 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company's lead iPSC derived Cymerus
  • Regenerative medicine dominated the market in 2021 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of USD 300,000 from MTPConnect's Industry Growth Centre Project Fund for the development of regenerative medicines in Australia
  • Cell acquisition technology held the largest market share in 2021 and is expected to expand at the fastest CAGR through 2022-2030 owing to increasing research studies involving cell harvesting
  • Allogenic therapy dominated the market in 2021 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
  • Pharmaceutical and biotechnology companies held the largest market share in 2021, and is anticipated to exhibit at fastest CAGR owing to upsurge in R&D, increasing clinical trials coupled with strategic activities by major market players
  • North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players in this region
  • Asia Pacific is expected to grow with the fastest CAGR of through 2022 to 2030 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China

Table of Contents

Chapter 1 Research Technologyology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Technologyology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Stem Cells Market Market Variables, Trends, & Scope

  • 4.1 Stem Cells Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Ongoing Developments In Regenerative Medicine
    • 4.4.2 Rising Funds For Accelerating Stem Cell Research
    • 4.4.3 Growing Demand For Stem Cell Banking
    • 4.4.4 Increasing Prevalence Of Genetic Disorders
  • 4.5 Market Restraint Analysis
    • 4.5.1 Ethical Concern Related To Stem Cell Research
    • 4.5.1 Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
  • 4.6 Key Opportunities
    • 4.6.1 Demand For Cell & Gene Therapies
  • 4.7 Key Challenge
    • 4.7.1 Technical Limitations Associated With Manufacturing Processes
  • 4.8 Stem Cells Market - Pestle Analysis
  • 4.9 Industry Analysis - Porter's
  • 4.10 Major Deals And Strategic Alliances Analysis
    • 4.10.1 Joint Ventures
    • 4.10.2 Mergers And Acquisitions
    • 4.10.3 Licensing And Partnership
    • 4.10.4 Technology Collaborations
    • 4.10.5 Strategic Divestments
  • 4.11 COVID-19 Impact Analysis

Chapter 5 Stem Cells Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 5.1 Global Stem Cells Market: Product Movement Analysis
  • 5.2 Adult Stem Cells (ASCs)
    • 5.2.1 Adult Stem Cells (Ascs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Hematopoietic Stem Cells (Blood Stem Cells)
      • 5.2.2.1 Hematopoietic stem cells (blood stem cells) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.3 Mesenchymal Stem Cells
      • 5.2.3.1 Mesenchymal stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.4 Neural Stem Cells
      • 5.2.4.1 Neural stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.5 Epithelial/Skin Stem Cells
      • 5.2.5.1 Epithelial/Skin stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.6 Other Adult Stem Cells
      • 5.2.6.1 Other adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3 Human Embryonic Stem Cells
    • 5.3.1 Human Embryonic Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Induced Pluripotent Stem Cells
    • 5.4.1 Induced Pluripotent Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Very Small Embryonic Like Stem Cells
    • 5.5.1 Very Small Embryonic Like Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Stem Cells Market- Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Stem Cells Market: Application Movement Analysis
  • 6.2 Regenerative Medicine
    • 6.2.1 Regenerative Medicine Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Neurology
      • 6.2.2.1 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 Orthopedics
      • 6.2.3.1 Orthopedics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Oncology
      • 6.2.4.1 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 Hematology
      • 6.2.5.1 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Cardiovascular and Myocardial Infraction
      • 6.2.6.1 Cardiovascular and myocardial infraction market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Injuries
      • 6.2.7.1 Injuries market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.8 Diabetes
      • 6.2.8.1 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.9 Liver Disorder
      • 6.2.9.1 Liver Disorder market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.10 Incontinence
      • 6.2.10.1 Incontinence market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.11 Others
      • 6.2.11.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3 Drug Discovery and Development
    • 6.3.1 Drug Discovery And Development Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Stem Cells Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

  • 7.1 Global Stem Cells Market: Technology Movement Analysis
  • 7.2 Cell Acquisition
    • 7.2.1 Cell Acquisition Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Bone Marrow Harvest
      • 7.2.2.1 Bone Marrow Harvest market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Umbilical Blood Cord
      • 7.2.3.1 Umbilical Blood Cord market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 Apheresis
      • 7.2.4.1 Apheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3 Cell Production
    • 7.3.1 Cell Production Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Therapeutic Cloning
      • 7.2.3.1 Therapeutic Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 In Vitro Fertilization
      • 7.3.3.1 In Vitro Fertilization market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 Cell Culture
      • 7.3.4.1 Cell Culture market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Isolation
      • 7.3.5.1 Isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Cryopreservation
    • 7.4.1 Cryopreservation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Expansion And Sub-Culture
    • 7.5.1 Expansion And Sub-Culture Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Stem Cells Market - Segment Analysis, By Therapy, 2018 - 2030 (USD Million)

  • 8.1 Global Stem Cells Market: Therapy Movement Analysis
  • 8.2 Autologous
    • 8.2.1 Autologous Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Allogenic
    • 8.3.1 Allogenic Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Stem Cells Market - Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 9.1 Global Stem Cells Market: End-User Movement Analysis
  • 9.2 Pharmaceutical And Biotechnology Companies
    • 9.2.1 Pharmaceutical And Biotechnology Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.3 Hospitals & Cell Banks
    • 9.3.1 Hospitals & Cell Banks Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.4 Academic & Research Institutes
    • 9.4.1 Academic & Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 10 Stem Cells Market: - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 10.1 Stem Cells Market: Regional Movement Analysis
  • 10.2 North America
    • 10.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.3 Europe
    • 10.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.2 U.K.
      • 10.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.3. Germany
      • 10.3.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.4 France
      • 10.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.5. Italy
      • 10.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.5 Spain
      • 10.3.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.2 Japan
      • 10.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.4.3 China
      • 10.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.4.4 India
      • 10.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.5 South Korea
      • 10.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.6 Australia
      • 10.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.3 Mexico
      • 10.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.4 Argentina
      • 10.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.6 Middle East & Africa (MEA)
    • 10.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.1 South Africa
      • 10.6.1.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.2 Saudi Arabia
      • 10.6.2.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.6.3 UAE
      • 10.6.3.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 Public Companies
    • 11.1.1 Company Market Position Analysis
    • 11.1.2 Competitive Dashboard Analysis
    • 11.1.3 Strategic Framework
  • 11.2 Private Companies
    • 11.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 11.2.2 Regional Network Map
  • 11.3 Company Profiles
    • 11.3.1 ADVANCED CELL TECHNOLOGY, INC.
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financial Performance
      • 11.3.1.3 Product Benchmarking
      • 11.3.1.4 Strategic Initiatives
    • 11.3.2 STEMCELL Technologies, Inc.
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Performance
      • 11.3.2.3 Product Benchmarking
      • 11.3.2.4 Strategic Initiatives
    • 11.3.3 CELLULAR ENGINEERING TECHNOLOGIES INC.
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financial Performance
      • 11.3.3.3 Product Benchmarking
      • 11.3.3.4 Strategic Initiatives
    • 11.3.4 CELLGENIX GmbH
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financial Performance
      • 11.3.4.3 Product Benchmarking
      • 11.3.4.4 Strategic Initiatives
    • 11.3.5 PROMOCELL GMBH
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financial Performance
      • 11.3.5.3 Product Benchmarking
      • 11.3.5.4 Strategic Initiatives
    • 11.3.6 LONZA
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financial Performance
      • 11.3.6.3 Product Benchmarking
      • 11.3.6.4 Strategic Initiatives
    • 11.3.7 KITE PHARMA
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financial Performance
      • 11.3.7.3 Product Benchmarking
      • 11.3.7.4 Strategic Initiatives
    • 11.3.8 CELLARTIS AB
      • 11.3.8.1 Company Overview
      • 11.3.8.2 Financial Performance
      • 11.3.8.3 Product Benchmarking
      • 11.3.8.4 Strategic Initiatives
    • 11.3.9 ANGEL BIOTECHNOLOGY
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financial Performance
      • 11.3.9.3 Product Benchmarking
      • 11.3.9.4 Strategic Initiatives
    • 11.3.10 BRAINSTORM CELL THERAPEUTICS
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financial Performance
      • 11.3.10.3 Product Benchmarking
      • 11.3.10.4 Strategic Initiatives
    • 11.3.11 CELGENE CORPORATION
      • 11.3.11.1 Company Overview
      • 11.3.11.2 Financial Performance
      • 11.3.11.3 Product Benchmarking
      • 11.3.11.4 Strategic Initiatives
    • 11.3.12 OSIRIS THERAPEUTICS, INC.
      • 11.3.12.1 Company Overview
      • 11.3.12.2 Financial Performance
      • 11.3.12.3 Product Benchmarking
      • 11.3.12.4 Strategic Initiatives
    • 11.3.13 GENEA BIOCELLS
      • 11.3.13.1 Company Overview
      • 11.3.13.2 Financial Performance
      • 11.3.13.3 Product Benchmarking
      • 11.3.13.4 Strategic Initiatives
    • 11.3.14 BIOHEART INC.
      • 11.3.14.1 Company Overview
      • 11.3.14.2 Financial Performance
      • 11.3.14.3 Product Benchmarking
      • 11.3.14.4 Strategic Initiatives
    • 11.3.15 WAISMAN BIOMANUFACTURING
      • 11.3.15.1 Company Overview
      • 11.3.15.2 Financial Performance
      • 11.3.15.3 Product Benchmarking
      • 11.3.15.4 Strategic Initiatives
    • 11.3.16 TIGENIX
      • 11.3.16.1 Company Overview
      • 11.3.16.2 Financial Performance
      • 11.3.16.3 Product Benchmarking
      • 11.3.16.4 Strategic Initiatives
    • 11.3.17 CALADRIUS
      • 11.3.17.1 Company Overview
      • 11.3.17.2 Financial Performance
      • 11.3.17.3 Product Benchmarking
      • 11.3.17.4 Strategic Initiatives
    • 11.3.18 GAMIDA CELL.
      • 11.3.18.1 Company Overview
      • 11.3.18.2 Financial Performance
      • 11.3.18.3 Product Benchmarking
      • 11.3.18.4 Strategic Initiatives
    • 11.3.19 PLURISTEM THERAPEUTICS INC.
      • 11.3.19.1 Company Overview
      • 11.3.19.2 Financial Performance
      • 11.3.19.3 Product Benchmarking
      • 11.3.19.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 14 North America Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 21 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 22 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 23 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 24 Canada Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 26 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 27 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 28 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 29 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 30 Europe Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 31 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 32 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 33 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 34 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 35 Germany Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 36 U.K. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 37 U.K. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 38 U.K. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 39 U.K. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 40 U.K. Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 41 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 42 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 43 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 44 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 45 France Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 46 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 47 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 48 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 49 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 50 Italy Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 51 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 52 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 53 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 54 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 55 Spain Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 56 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 57 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 58 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 59 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 60 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 61 Asia Pacific Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 62 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 63 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 64 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 65 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 66 China Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 67 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 68 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 69 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 70 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 71 Japan Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 72 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 73 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 74 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 75 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 76 India Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 77 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 78 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 79 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 80 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 81 South Korea Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 82 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 83 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 84 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 85 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 86 Australia Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 87 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 88 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 89 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 90 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 91 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 92 Latin America Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 93 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 94 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 95 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 96 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 97 Brazil Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 98 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 99 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 100 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 101 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 102 Mexico Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 103 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 104 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 105 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 106 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 107 Argentina Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 108 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 109 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 110 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 111 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 112 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 113 Middle East & Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 114 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 115 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 116 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 117 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 118 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 119 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 120 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 121 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 122 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 123 Saudi Arabia Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 124 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 125 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 126 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 127 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 128 UAE Stem Cells Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Stem Cells Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Stem Cells Market: Product Movement Analysis
  • FIG. 17 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 18 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
  • FIG. 19 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 20 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 21 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 22 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 23 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 24 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 25 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 26 Global Stem Cells Market: Application Movement Analysis
  • FIG. 27 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
  • FIG. 28 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
  • FIG. 29 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
  • FIG. 30 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
  • FIG. 31 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
  • FIG. 32 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
  • FIG. 33 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
  • FIG. 34 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
  • FIG. 35 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
  • FIG. 36 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
  • FIG. 37 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 38 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
  • FIG. 39 Global Stem Cells Market: Technology Movement Analysis
  • FIG. 40 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
  • FIG. 41 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
  • FIG. 42 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
  • FIG. 43 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
  • FIG. 44 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
  • FIG. 45 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
  • FIG. 46 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
  • FIG. 47 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
  • FIG. 48 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
  • FIG. 49 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
  • FIG. 50 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
  • FIG. 51 Global Stem Cells Market: Therapy Movement Analysis
  • FIG. 52 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
  • FIG. 53 Global Stem Cells Market, for Allogenic, 2018 - 2030 (USD Million)
  • FIG. 54 Global Stem Cells Market, End-User Movement Analysis
  • FIG. 55 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 56 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
  • FIG. 57 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 58 Regional Marketplace: Key Takeaways
  • FIG. 59 Regional Outlook, 2021 & 2030
  • FIG. 60 Global Stem Cells Market: Region Movement Analysis
  • FIG. 61 North America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 62 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 63 Canada Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 64 Europe Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 65 Germany Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 66 U.K. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 67 France Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 68 Italy Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 69 Spain Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 76 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 77 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 78 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 79 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 80 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 81 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 82 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 83 UAE Stem Cells Market, 2018 - 2030 (USD Million)